US$ 27.18
bpc-157 typical human dose mcg Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or dosing for bpc 157 peptide
Description
10.1093/jn/138.6.1067 3 AndersonR

No FDA approval
Cyanocobalamin

The usual dose is 1000 mcg, but it might change based on how severe the deficiency is

No human clinical trials exist for TB-500

Stable Gastric Pentadecapeptide BPC 157 in the Treatment of Colitis and Ischemiaand Reperfusion in Rats: New Insights
